The Centre is expecting Zydus Cadila’s needle-free coronavirus vaccine ZyCoV-D to be available in early October, according to news agency ANI‘s report.
Indigenously developed Zydus Cadila’s ZyCoV-D last month received approval for Emergency Use Authorisation from the drug regulator, making it the first vaccine in India which would be administered in the age group of 12-18 years.
Covishield, Covaxin and Sputnik V vaccines are being given to only those above 18 years and unlike ZyCoV-D, which is three-dose, these are administered in two doses.
The Department of Biotechnology (DBT) had earlier said that ZyCoV-D is the world’s first DNA-based vaccine against Covid-19 and when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response, which plays a vital role in protection from the disease as well as viral clearance.
It said that interim results from Phase-III clinical trials in over 28,000 volunteers showed primary efficacy of 66.6 per cent for symptomatic RT-PCR positive cases. This has been the largest vaccine trial so far in India for COVID-19, the DBT said.
The Covid-19 vaccine had already exhibited robust immunogenicity and tolerability and safety profile in the adaptive phase one and two clinical trials. Both Phase one/two and Phase three clinical trials have been monitored by an independent data safety monitoring board, the DBT added.
Rice water, rich in inositol, antioxidants, vitamins, and minerals, protects hair from sunlight damage and…
Natural Remedies for Bloating: 8 Herbs and Supplements That Work Wonders for Your Gut Health…
Benefits of Oil Pulling: Stops Bad Breath, Keeps Gums Healthy, But Can't Replace Brushing Oil…
Spicy food – whether it’s a dash of chili in your curry, a spoonful of…
How To Identify Adulterated Wheat Flour? Try These 4 Easy Tests Wheat flour is a…
Reasons That Will Make You Eat Jaggery After Every Meal (Potential Health Benefits Inside) Jaggery,…